Nadine Wentzell

  • Since September 2014 Research Fellow at Leibniz Institute für Prevention Research and Epidemiology - BIPS
  • May 2014 – September 2014 Research Fellow at Hamburg University of Applied Sciences
  • March 2014 – September 2014 Temporary Lecturer at Hamburg University of Applied Sciences
  • March 2014 Master of Science in Health Sciences, Hamburg University of Applied Sciences (Master Thesis: Exploratory Analysis of Biologicals in the Drug Treatment of Patients with Crohn's Disease using Administrative Claims Data)
  • September 2011 Bachelor of Arts in Public Health Political Sciences, University of Bremen

  • Drug Utilization and Drug Safety, especially during pregnancy
  • Biologicals

    Selected BIPS-Publications

  • Articles with peer review

  • Amann U, Wentzell N, Kollhorst B, Haug U. Prescribing of endothelin receptor antagonists and riociguat in women of childbearing age in a large German claims database study. Reproductive Toxicology. 2023;119:108415.
    https://doi.org/10.1016/j.reprotox.2023.108415
  • Reinold J, Kollhorst B, Temme HL, Wentzell N, Haug U. Use of acitretin among girls and women of childbearing age and occurrence of acitretin-exposed pregnancies in Germany. Clinical Drug Investigation. 2023;43(11):865-872.
    https://doi.org/10.1007/s40261-023-01314-2
  • Wentzell N, Kollhorst B, Reinold J, Haug U. Use of methotrexate in girls and women of childbearing age, occurrence of methotrexate-exposed pregnancies and their outcomes in Germany: A claims data analysis. Clinical Drug Investigation. 2023;43(2):109-117.
    https://doi.org/10.1007/s40261-022-01227-6
  • Platzbecker K, Wentzell N, Kollhorst B, Haug U. Fingolimod, teriflunomide and cladribine for the treatment of multiple sclerosis in women of childbearing age: Description of drug utilization and exposed pregnancies in Germany. Multiple Sclerosis and Related Disorders. 2022;67:104184.
    https://doi.org/10.1016/j.msard.2022.104184
    https://repository.publisso.de/resource/frl:6435355
  • Wentzell N, Haug U. Characterization of pregnancies among women with epilepsy using valproate before or during pregnancy - A longitudinal claims data analysis from Germany. Epilepsy Research. 2022;179:106838.
    https://doi.org/10.1016/j.eplepsyres.2021.106838
    https://repository.publisso.de/resource/frl:6431122
  • Schäfer W, Wentzell N, Schink T, Haug U. Characterization of pregnancies exposed to St. John's wort and their outcomes: A claims data analysis. Reproductive Toxicology. 2021;102:90-97.
    https://doi.org/10.1016/j.reprotox.2021.04.005
    https://repository.publisso.de/resource/frl%3A6428346
  • Schink T, Wentzell N, Dathe K, Onken M, Haug U. Estimating the beginning of pregnancy in German claims data: Development of an algorithm with a focus on the expected delivery date. Frontiers in Public Health. 2020;8:350.
    https://doi.org/10.3389/fpubh.2020.00350
  • Wentzell N, Haug U, Schink T, Engel S, Liebentraut J, Linder R, Onken M, Schaefer C, Dathe K. Valproatverordnungen bei Mädchen und Frauen im gebärfähigen Alter in Deutschland: Untersuchung zeitlicher Trends basierend auf Versichertendaten. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2018;61(8):1022-1029.
    https://doi.org/10.1007/s00103-018-2768-1
  • Wentzell N, Schink T, Haug U, Ulrich S, Niemeyer M, Mikolajczyk R. Optimizing an algorithm for the identification and classification of pregnancy outcomes in German claims data. Pharmacoepidemiology and Drug Safety. 2018;27(9):1005-1010.
    https://doi.org/10.1002/pds.4588
    https://repository.publisso.de/resource/frl%3A6417552

  • Articles without peer review

  • Schink T, Wentzell N, Haug U. Arzneimittel in der Schwangerschaft - Potenzial von Sekundärdaten. Public Health Forum. 2017;25(3):221-223.
    https://doi.org/10.1515/pubhef-2017-0026

  • Presentations at scientific meetings/conferences

  • Schäfer W, Wentzell N, Kollhorst B, Haug U. Antidepressant use in early pregnancy: Prevalence and pregnancy outcomes. Workshop der Arbeitsgemeinschaft Pharmakoepidemiologie der Deutschen Gesellschaft für Epidemiologie (DGEpi) und der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie (GMDS), 20.-21. Juni 2023, Bremen.
  • Wentzell N, Kollhorst B, Schink T. Time trends of HIV treatment in girls and women of childbearing age in Germany. 18. Jahrestagung der Deutschen Gesellschaft für Epidemiologie (DGEpi), 26.-28. September 2023, Würzburg.
  • Schink T, Wentzell N, Dathe K, Onken M, Haug U. Fetotoxicity of RAAS-inhibitors. 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 16-17 September 2020, online presentation. (Abstract published in: Pharmacoepidemiology & Drug Safety. 2020;29(S3):3705)
  • Wentzell N, Haug U, Schink T, Engel S, Liebentraut J, Linder R, Onken M, Schaefer C, Dathe K. Valproatverordnungen bei Mädchen und Frauen im gebärfähigen Alter in Deutschland: Untersuchungen zeitlicher Trends basierend auf Versicherungsdaten. 13. Jahrestagung der Deutschen Gesellschaft für Epidemiologie (DGEpi), 26.-28. September 2018, Bremen.

  • Posters at scientific meetings/conferences

  • Kollhorst B, Wentzell N, Niemeyer M, Haug U, Schink T. Identification of pregnancies without a recorded outcome in German claims data. 39th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 23-27 August 2023, Halifax, Canada. (Abstract published in: Pharmacoepidemiology and Drug Safety. 2023;32(S1):516-517)
  • Wentzell N, Kollhorst B, Schink T. Time trends of HIV treatment in girls and women of childbearing age in Germany. 39th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 23-27 August 2023, Halifax, Canada. (Abstract published in: Pharmacoepidemiology and Drug Safety. 2023;32(S1):523)
  • Wentzell N, Kollhorst B, Haug U. Use of methotrexate in girls and women of childbearing age and occurrence of methotrexate-exposed pregnancies in Germany. 38th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 24-28 August 2022, Copenhagen, Denmark. (Abstract published in: Pharmacoepidemiology and Drug Safety. 2022;31(Suppl. 2):292)
  • Schäfer W, Wentzell N, Haug U. St. John's Wort: Utilization during pregnancy and pregnancy outcomes. 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 16-17 September 2020, online poster. (Abstract published in: Pharmacoepidemiology & Drug Safety. 2020;29(S3):3719)
  • Wentzell N, Schink T, Witzleb AJ, Haug U. Utilization patterns of valproate in women with epilepsy before and during pregnancy. 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 16-17 September 2020, online poster. (Abstract published in: Pharmacoepidemiology & Drug Safety. 2020;29(S3):3844)
  • Witzleb AJ, Wentzell N, Schink T, Haug U. Exploratory analyses of modafinil utilization during pregnancy and diagnoses of malformations in the offspring. 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 16-17 September 2020, online poster. (Abstract published in: Pharmacoepidemiology & Drug Safety. 2020;29(S3):3704)
  • Wentzell N, Haug U, Dathe K, Onken M, Schink T. Information on the expected delivery date in German claims data: Assessing its potential to estimate the beginning of pregnancy. 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 22-26 August 2018, Prague, Czech Republic.
  • Wentzell N, Haug U, Schink T, Engel S, Liebentraut J, Linder R, Onken M, Schaefer C, Dathe K. Prescribing valproate to girls and women of childbearing age in Germany: Analysis of trends based on claims data. 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 22-26 August 2018, Prague, Czech Republic.

For further publications please follow this link:

  • Social and Health Management at Institute for Further Training at University of Hamburg Public Health, 2015 - 2017
  • European Master of Science in Epidemiology at Johannes Gutenberg-University Mainz Secondary data for health research, WT 2016/2017, WT 2017/2018, WT 2019/2020

The responsibility for the content of this page lies with Nadine Wentzell.

Contact

Phone:
+49 (0)421 218-56-879
e-mail:
wentzell(at)leibniz-bips.de